[1]
Watanabe, N. et al. 2014. Crizotinib-induced acute interstitial lung disease in a patient with EML4-ALK positive non-small cell lung cancer and chronic interstitial pneumonia. Acta Oncologica. 53, 1 (Jan. 2014), 158–160. DOI:https://doi.org/10.3109/0284186X.2013.802838.